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SUMMARY 
LH pulse secretion changes during the menstrual cycle from a rapid regular 
pattern in the follicular phase to a slower and irregular pattern in the luteal 
phase. To determine whether the irregular LH pulse pattern in the luteal phase 
reflects altered GnRH secretion or altered pituitary responsiveness to GnRH, 
we gave low dose GnRH pulses (25 ng/kg i.v.) every 2 h or every hour for 10 or 
12 d to three women with isolated GnRH deficiency. After 4 d of GnRH alone, 
oestradiol (E2) was given and after 6 d progesterone (P) was added to mimic the 
hormonal milieu of the luteal phase. LH and FSH were measured every 4 h 
throughout and also every 20 min for 6 or 12 h, before and after GnRH alone 
(day 0 and day 4), after E2 (day 6), and after E2+P (day 10 and day 12). Both 
GnRH pulse frequencies resulted in a rapid increase in plasma FSH to peaks on 
day 4 (every 2 h) and day 2 and 3 (every hour). FSH concentrations then 
declined as plasma E2 rose to 50-80 pg/ml reflecting the selective inhibitory 
effect of E2 on FSH release. Plasma LH was also increased after the hourly 
GnRH injections and this regimen was associated with a more rapid rise in E2 
reflecting follicular maturation. In contrast to the differences in mean hormone 
concentrations, administration of GnRH at both frequencies resulted in 
sustained one-on-one responsiveness of LH that was maintained in the presence 
of both oestrogen and progesterone at mid-luteal phase concentrations. We 
conclude that the slow frequency of LH pulses observed during the luteal phase 
reflects decreased GnRH pulse frequency rather than impaired pituitary 
responsiveness to GnRH. 
Correspondence: J. C. Marshall, M.D., Ph.D., University of Michigan Hospital, Department of Internal 
Medicine, 31 10E Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0368, USA. 
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Plasma concentrations of pituitary gonadotrophins (FSH and LH) fluctuate in a pulsatile 
manner throughout the menstrual and oestrous cycles of humans and other species 
(Cargille et al., 1969; Johansson et al., 1971; Midgley & Jaffe, 1971; Yen et al., 1972; 
Santen & Bardin, 1973; Baird, 1978; Backstrom et al., 1982; Reame et al., 1984; Filicori et 
al., 1986). Marked differences have been found in the patterns of LH secretion during the 
follicular and luteal phases of the cycle: in the former, LH pulses are regular, frequent 
(every 50-100 min), and of uniform amplitude; whereas the luteal phase is characterized 
by infrequent, irregular pulses of variable amplitude. The mechanisms of these different 
secretory patterns are unclear but they have been presumed to reflect altered GnRH 
secretion produced by the changing steroid milieu. This view stems mainly from studies 
showing preserved pituitary responsiveness to a single (Nillius & Wide, 1972) or up to five 
pharmacological pulses of GnRH given at 2-h intervals during the luteal phase of the 
cycle (Wang et al., 1976). The possibility remains, however, that luteal phase gonadal 
steroid concentrations may alter gonadotrophin responses to repeated physiological 
pulses of GnRH by a direct effect at the pituitary level. 
The present study was designed to determine whether pituitary responsiveness to 
GnRH was maintained on a one-to-one basis in the presence of a steroid milieu similar to 
that present during the luteal phase of the cycle. If uniform LH responsiveness were 
maintained, the data would provide strong support for the supposition that the slow, 
irregular LH pulse patterns normally observed in the luteal phase are representative of 
altered hypothalamic GnRH secretion, rather than changed pituitary sensitivity to 
GnRH. To avoid problems of interpreting the results in the presence of endogenous 
GnRH secretion, we studied three female patients with isolated gonadotrophin deficiency 
who received ‘physiological’ doses of GnRH (25 ng/kg per pulse) at hourly or two-hourly 
intervals throughout a 10-12 d period. 
MATERIALS AND METHODS 
Patients studied 
Patient 1 was an 18-year-old woman with primary amenorrhoea and hyposmia. The 
patient was adopted and no family history was available. Physical examination revealed 
lack of pubertal development (Tanner stage 1) and an otherwise healthy woman (height 
155.6 cm, weight 47.4 kg). 
Patient 2 was a 21-year-old woman who presented initially with primary amenorrhoea 
and lack of pubertal development. She had an intact sense of smell. Her 18-year-old sister 
also had absent sexual development and primary amenorrhoea. The patient had 
previously received oestrogen therapy for 2 years which resulted in the development of 
secondary sexual characteristics (Tanner stage 4). Physical examination was normal 
(height I54 cm, weight 54.4 kg). She had not received any medication for I year before the 
study. 
Patient 3 was a 20-year-old woman with primary amenorrhoea and delayed pubertal 
development. Her sense of smell was intact. There was no family history of infertility, 
however one sister was under treatment for irregular menses. Physical examination 
revealed minimal breast development (Tanner stage 2). The remainder of the examination 
was normal (height 165.1 cm, weight 47.9 kg). 
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All three patients had normal prolactin concentrations, thyroid function tests and 
imaging of the sella turcica (sella roentgenograms in patients 1 and 2, and CT scan in 
patient 3). Patient 1 also had normal GH, cortisol and TSH response to a combined 
insulin hypoglycaemia/TRH test. 
Study protocol 
The studies were approved by the Institutional Review Board and performed at the 
Clinical Research Center of The University of Michigan Hospitals. Written informed 
consent was obtained from the patients before the study. 
Patients 1 and 2 were studied for 10 d and patient 3 for 12 d. Pulse injections of GnRH 
(25 ng/kg body weight) in normal saline were given intravenously beginning on day 1 and 
continued throughout the study. Injections were given every 2 h to patient 1 and every 
hour to patients 2 and 3. On day 0 (control day) saline pulses were given at the same 
frequency. 
At 2000 h on day 4, micronized 17,!hestradiol (Estrace, Mead Johnson Laboratories, 
Evansville, Indiana, USA) was begun orally with a loading dose of 2 mg and then 1 mg 
was continued every 8 h throughout the study (days 5-10 in patients 1 and 2, days 5-12 in 
patient 3). At 2000 h on day 6 progesterone in oil was begun with a loading dose of 0.4 mg/ 
kg i.m. and 0.2 mg/kg was given every 12 h on subsequent days. 
Blood for measurement of LH and FSH was obtained every 4 h throughout the study 
and every 20 min for variable periods of time on each study day to assess the 
gonadotrophin response to the GnRH injections. In patients 1 and 2 the periods of 
frequent sampling were for 12 consecutive hours on day 0 (240&1200 h), and on days 4,6, 
and 10 (0800-2000 h), and for two consecutive hours on each other day. For patient 3 the 
periods of frequent sampling were for 8 h (2400-0400 h, 0800-1200 h) on day 0, six 
consecutive hours (0800-1400 h) on days 4,6, 10 and 12, and for two consecutive hours 
(0800-1000 h) on each other day. 
Serum levels of oestradiol (Ez), progesterone (P) and oestrone (El; patients 1 and 2 
only) were measured every 12 h (0800 and 2000 h) throughout the study. All blood 
samples were centrifuged and the plasma was separated and stored at -20°C until 
assayed. 
Hormone assays and data analysis 
Plasma LH (Midgley, 1966), FSH (Midgley, 1967), El, Ez (England et al., 1974), and P 
(Niswender, 1973) were measured by established radioimmunoassay methods. Gonado- 
trophin concentrations are reported in mIU of the Second International Reference 
Preparation of hMG after conversion from LER 907, which was used as the assay 
standard. For LH and FSH the intra-assay coefficient of variation (CV) was inversely 
proportional to the measured amount and for concentrations of 2 5 7 . 5 ,  and 15 mIU/ml 
averaged 20%, 9.5% and 6.6%, respectively. The interassay CV was 1 1 % for the LH and 
FSH assays and 15% for the E2 and P assays. For statistical analyses, values below assay 
sensitivity were assigned a value of assay sensitivity. El and Ez concentrations are 
expressed as pg/ml (1 pg/ml oestrone = 3.7 pmol/l; 1 pg/ml oestradiol = 3.7 pmol/l). 
Progesterone concentrations are expressed as ng/ml (1 ng/ml progesterone = 3.2 nmol/l). 
A significant LH pulse was defined as a rise from nadir to peak within 40 min by a 
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Fig. 1. FSH (0) and LH (0) responses to GnRH pulses in patient 1 during 12 h frequent (q20min) 
sampling periods on days 0, 4, 6 and 10. 
minimal detectable increment (MDI) as determined by twice the intra-assay coefficient of 
variation (CV) of replicate samples from each individual patient (MDI = mean LH 
value x CV x 2) (Reame et al., 1984). The MDI calculated in this manner is very similar to 
that obtained by using the criterion of three times the assay CV above the LH nadir value. 
LH and FSH pulse amplitudes were determined by the difference between nadir and peak 
values for each significant gonadotrophin pulse. Gonadotrophin pulse amplitudes were 
compared using Student's t-test. 
RESULTS 
Figures 1 ,2  and 3 show plasma FSH and LH concentrations during the periods of 20 min 
sampling in patients 1 , 2  and 3, respectively. Frequent sampling periods were selected on 
day 0 (saline pulses), day 4 (after 4 d of GnRH pulses), day 6 (2 d after the addition of 
Estrace), day 10 (after 4 d of combined Ez and P administration) and in patient 3, on day 
12 (after 6 d of combined Ez and P administration). 
Significant LH and FSH pulses were not present on day 0 (saline injections) in all 
patients, however a significant LH response occurred after every GnRH injection on days 
4,6, 10 and 12. The amplitude of LH pulses on these days were comparable over time in 
patient 1 (1.5f0.4, 1 . 1  +0.2 and 1.6k0.2 mIU/ml, mean+SEM) and in patient 3 
(3.2 f 0.6, 3.5 k 0.8, 4.2 f0.5,  4.7 i- 1.0 mIU/ml). In patient 2, LH pulse amplitude was 
similar on days 4 and 6 (3.4f 1.0 and 4.4f 1.3 mIU/ml) but was higher on day 10 
(6.1 k 2.4 mIU/ml, P < 0.0005 vs day 4; P < 0.05 vs day 6). FSH responses occurred after 
each GnRH injection in patient 1 and the amplitudes of each FSH pulse were comparable 
(1.2f0.2, 1.2f0.3, 1 . O f O . l  mIU/ml). In patients 2 and 3, FSH pulses occurred 
'irregularly in response to hourly GnRH injections on days 4, 6, 10 and 12. On day 10 in 
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patient 2, FSH was below assay detectability for six of the 12 h studied and significant 
FSH responses did not occur. 
The mean plasma gonadotrophin concentrations (mean of every 4 h samples between 
0800-2000 h and 2000-0800 h) and the oestradiol and progesterone concentrations 
during the 10-12 d study period for all three patients are shown in Fig. 4. In patient I ,  
(GnRH injections every 2 h) gonadotrophin levels were low (< 1 mIU/ml) on the control 
day. Preinjection levels of FSH began to increase after only two or three GnRH pulse 
injections and continued to rise to a peak (8.3 mIU/ml) on day 4. After the first dose of 
Estrace, plasma FSH declined through day 6 after which time FSH concentrations 
remained stable (approximately 4 mIU/ml). Plasma LH concentrations increased slowly 
and continued to rise through day 10 reaching a maximum of 2.3 mIU/ml. In patient 2 and 
3, (hourly GnRH injections) mean gonadotrophin concentrations were also low during 
saline injections on the control day (< 1.6 mIU/ml). The increase in preinjection levels of 
FSH occurred more rapidly than in patient 1, reaching a peak concentration of 9.1 mIU/ 
ml at 0800 h on day 2 in patient 2 and 13.9 mIU/ml at 0800 h on day 3 in patient 3. FSH 
concentrations began to decline before administration of Estrace and continued to 
decrease for the remainder of the study reaching undetectable levels by day 8 in patient 2, 
and 1.9 mIU/ml by day 12 in patient 3. Preinjection levels of LH increased rapidly in these 
two patients and continued to rise to day 6. At this time in patient 2,  a few hours after the 
first P injection was given, a large LH peak occurred (27 mIU/ml) and persisted for 6 h. 
For the remainder of the study mean LH concentrations varied between 7 and 14.4 mIU/ 
ml. 
Plasma oestradiol rose little in patient 1 and was only 45 pg/ml before Estrace 
administration on day 4. Subsequently, E2 rose to a maximum of 200 pg/ml on days 8 and 
9. The low E2 value on day 10 (40 pg/ml) was related to the omission of one Estrace dose. 
Day 0 Day 4 Day 6 Day 10 
Fig. 2. FSH (0 )  and LH (0) responses to GnRH pulses in patient 2 during 12 h frequent (q20min) 
sampling periods on days 0, 4, 6 and 10. 
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Fig. 3.  FSH (0 )  and LH (0) responses to GnRH pulses in patient 3 during 6 h frequent (q20min) 
sampling periods on days 0, 4, 6, 10 and 12. 
Plasma E2 rose to values greater than 80 pg/ml in patients 2 and 3 before the first Estrace 
dose. E2 continued to rise and reached 800 pg/ml on day 10 in patient 2 and 550 pg/ml in 
patient 3. In patients 1 and 2 plasma El values were unchanged throughout the first four 
days of the study and averaged 88 & 14 pg/ml in patient 1 and 135 & 9 pg/ml in patient 2 
(mean f SEM). As expected, plasma El levels were increased after Estrace administration 
and averaged 707 k 84 and 529 f 69 pg/ml in patients 1 and 2, respectively. 
Plasma progesterone was initially low (GO.4 ng/ml) in all patients and remained so 
before P administration in patients 1 and 3. In patient 2 plasma P rose to 0.7-2 ng/ml on 
days 5 and 6 before P administration. After P injections were begun on day 6,  similar 
concentration of P were present in all three patients, and varied between 6 and 15 ng/ml. 
DISCUSSION 
In this study, we aimed to define the effect of E2 and P on the patterns of gonadotrophin 
secretion in response to pulsatile administration of GnRH in three patients with GnRH 
deficiency. Specifically, the study was designed to determine whether consistent LH 
responsiveness to GnRH pulses was maintained in the presence of E2 and P concentra- 
tions to mimic the luteal phase steroid milieu. The GnRH dose (25 ng/kg body weight) 
was chosen to simulate the presumed pituitary portal concentrations of GnRH (Kelch et 
al., 1975; Carmel et al., 1976; Neil1 et al., 1977; Eskay et al., 1977; Sarkar et al., 1978; 
Marshall & Kelch, 1979; Crowley & McArthur, 1980; Valk et al., 1980, 1981) and the 
injection intervals used (60-1 20 min) were similar to LH pulse frequencies observed 
during the follicular phase of normal menstrual cycles (Midgley & Jaffe, 1971; Yen et al., 
1972; Filicori et al., 1982; Reame et al., 1984; Soules et al., 1984). 
LH and FSH concentrations tended to rise more rapidly after the faster frequency of 
GnRH stimulation. The peak level and decline in plasma FSH was not influenced by 
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Fig. 4. Mean preinjection plasma gonadotrophins (mean SEM of samples every 4 h from 0800 
to 2000 h and 2000 to 0800 h) are shown in the upper two panels, and gonadal steroid 
concentrations a t  0800 hand 2000 h are shown in the lower two panels. Closed symbols are data 
from patient 1 (GnRH q2h) and open symbols are data from patients 2 (0) and 3 (A) (GnRH 
qlh). TID, Three times daily; BID, twice daily. 
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GnRH pulse frequency and FSH began to decline in all patients when plasma E2 levels 
exceeded 50-80 pg/ml. This is in agreement with our previous observations that Ez 
selectively inhibits FSH secretion (Marshall er al., 1983), and a further increase in EZ in 
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patient 2 (from endogenous and exogenous sources, as reflected in the lower EI/E2 ratio 
observed on days 5-10) resulted in a fall in FSH to unmeasurable levels. 
Consistent one-to-one responses of LH to GnRH pulses given at both frequencies were 
observed in the presence of luteal phase concentrations of P and in the presence of a wide 
range of plasma El levels (45-800 pg/ml). These findings support and extend previous 
observations which showed preserved pituitary responses to a single (Nillius & Wide, 
1972) or up to five successive pharmacological doses of GnRH during the luteal phase in 
normal cycling women (Wang et al., 1976). Observations in normal cycling women 
suggest that the duration of pituitary exposure to P used in the present study (4 and 6 d of 
mid-luteal phase concentrations of P) should be adequate for any effect of P on pituitary 
responsiveness to be manifest. In normal women, LH secretion shows a slow frequency, 
irregular pattern by day 18-19 of the cycle (Reame et al., 1984) and this pattern has been 
noted 2 d after the mid-cycle LH surge (Filicori et al., 1984). Similarly, LH pulse 
frequency is reduced after 5 d of P administration to oestrogen-replaced ovariectomized 
ewes (Goodman et al., 1981). Overall, these data indicate that the decrease in LH pulse 
frequency seen during the normal luteal phase of the cycle reflects an effect of ovarian 
steroids on the frequency of GnRH secretion and not an alteration in the ability of the 
pituitary to maintain responsiveness to GnRH. 
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